Insider Transactions in Q2 2024 at Oncology Institute, Inc. (TOI)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 17
2024
|
Brad Hively Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
18,121
-2.61%
|
$0
$0.46 P/Share
|
|
May 22
2024
|
Brad Hively Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
19,526
-2.74%
|
$0
$0.58 P/Share
|
|
May 21
2024
|
Jeremy Castle Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
70,120
+45.96%
|
-
|
|
May 21
2024
|
Yale Podnos Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,530
+14.38%
|
-
|
|
May 21
2024
|
Mihir Shah Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
151,459
+24.18%
|
-
|
|
May 21
2024
|
Daniel Virnich Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
198,517
+17.8%
|
-
|
|
May 21
2024
|
Daniel Virnich Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
11,173
-1.53%
|
$0
$0.6 P/Share
|